These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 16474521
1. The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy. Stephenson AJ, Slawin KM. Nat Clin Pract Urol; 2004 Dec; 1(2):90-6. PubMed ID: 16474521 [Abstract] [Full Text] [Related]
3. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Bianco FJ, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA. Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):448-53. PubMed ID: 15890586 [Abstract] [Full Text] [Related]
4. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis. Bernard JR, Buskirk SJ, Heckman MG, Diehl NN, Ko SJ, Macdonald OK, Schild SE, Pisansky TM. Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):735-40. PubMed ID: 19464818 [Abstract] [Full Text] [Related]
5. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M, Shinohara K. BJU Int; 2009 Sep 01; 104(5):600-4. PubMed ID: 19245439 [Abstract] [Full Text] [Related]
6. Evaluation and management of prostate-specific antigen recurrence after radical prostatectomy for localized prostate cancer. Naito S. Jpn J Clin Oncol; 2005 Jul 01; 35(7):365-74. PubMed ID: 15976063 [Abstract] [Full Text] [Related]
7. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy. Heidenreich A, Richter S, Thüer D, Pfister D. Eur Urol; 2010 Mar 01; 57(3):437-43. PubMed ID: 19303197 [Abstract] [Full Text] [Related]
8. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. Leonardo C, Simone G, Papalia R, Franco G, Guaglianone S, Gallucci M. Int J Urol; 2009 Jun 01; 16(6):584-6. PubMed ID: 19453762 [Abstract] [Full Text] [Related]
9. Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy. Neuhof D, Hentschel T, Bischof M, Sroka-Perez G, Hohenfellner M, Debus J. Int J Radiat Oncol Biol Phys; 2007 Apr 01; 67(5):1411-7. PubMed ID: 17275204 [Abstract] [Full Text] [Related]
11. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience. Siddiqui SA, Mynderse LA, Zincke H, Hoffmann NE, Lobo JR, Wilson TM, Kawashima A, Davis BJ, Blute ML. Urology; 2007 Jul 01; 70(1):80-5. PubMed ID: 17656213 [Abstract] [Full Text] [Related]
12. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited. Vaidya A, Soloway MS. J Urol; 2000 Dec 01; 164(6):1998-2001. PubMed ID: 11061900 [Abstract] [Full Text] [Related]
13. Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy. King CR, Presti JC, Brooks JD, Gill H, Spiotto MT. Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1472-7. PubMed ID: 17935902 [Abstract] [Full Text] [Related]
14. Perineal salvage prostatectomy for radiation resistant prostate cancer. van der Poel HG, Beetsma DB, van Boven H, Horenblas S. Eur Urol; 2007 Jun 01; 51(6):1565-71; discussion 1572. PubMed ID: 16949728 [Abstract] [Full Text] [Related]
15. Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1530-5. PubMed ID: 15050333 [Abstract] [Full Text] [Related]
16. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Paparel P, Cronin AM, Savage C, Scardino PT, Eastham JA. Eur Urol; 2009 Feb 01; 55(2):404-10. PubMed ID: 18639970 [Abstract] [Full Text] [Related]
17. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Simmons MN, Stephenson AJ, Klein EA. Eur Urol; 2007 May 01; 51(5):1175-84. PubMed ID: 17240528 [Abstract] [Full Text] [Related]
18. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Lee B, Shinohara K, Weinberg V, Gottschalk AR, Pouliot J, Roach M, Hsu IC. Int J Radiat Oncol Biol Phys; 2007 Mar 15; 67(4):1106-12. PubMed ID: 17197119 [Abstract] [Full Text] [Related]
19. PSA relapse prostate cancer: the importance of tailored therapy. Aranha O, Vaishampayan U. Urol Oncol; 2004 Mar 15; 22(1):62-9. PubMed ID: 14969807 [Abstract] [Full Text] [Related]
20. Treatment of men with rising prostate-specific antigen levels following radical prostatectomy. Tzou K, Tan WW, Buskirk S. Expert Rev Anticancer Ther; 2011 Jan 15; 11(1):125-36. PubMed ID: 21166517 [Abstract] [Full Text] [Related] Page: [Next] [New Search]